Perspective: Overcoming Obstacles to Medication-Assisted Treatment

March 27, 2020

Lena Marceno

Medication-assisted treatment (MAT) is considered the gold standard of opioid use disorder treatment when paired with behavioral therapies, yet the number of primary care providers who practice MAT is surprisingly low. 

To better understand why more primary care providers are not practicing MAT, our team at Altarum interviewed several medical, social services, and recovery community providers in Michigan who practice or support MAT to learn about obstacles they face in delivering this critical treatment. 

Lena Marceno, a program manager in our Center for Behavioral Health, outlines key insights from these interviews and steps to overcome barriers to MAT in Addiction Professional. Read the article “Three Steps to Overcoming Obstacles to MAT”. 

###
Altarum is a nonprofit organization that works with federal and state agencies and foundations to improve the health of at-risk and disenfranchised populations by building better systems of care. We achieve measurable results by combining our expertise in public health and health care delivery with technology, workforce training and continuing education, applied research, and technical assistance. Our innovative solutions lead to better health for beneficiaries and better value for payers.
Overcoming Obstacles to Medication-Assisted Treatment

Perspective

Lena Marceno

Lena Marceno  - MSc

Areas of Expertise
  • Opioid Overdose/Substance Use Prevention
  • Evidence-Based Programming
  • Health Equity/Reduction of Health Disparities

Lena Marceno is a Program Manager for Altarum’s Center for Behavioral Health where she manages projects related to opioid misuse and substance use disorder for a variety of federal and state government clients. Additionally, Ms. Marceno has robust primary prevention experience, including stakeholder engagement; program design and implementation; and data collection and dissemination. Lena holds a bachelor’s degree from Northeastern University and a master’s degree in International Health Policy from the London School of Economics and Political Science.